| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 45.073 | 87.373 | 62.513 | 45.292 | 7.736 | 0 |
| Total Income - EUR | - | - | - | - | 45.073 | 87.373 | 62.514 | 45.293 | 7.762 | 0 |
| Total Expenses - EUR | - | - | - | - | 43.648 | 81.521 | 63.645 | 51.437 | 10.482 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.425 | 5.852 | -1.132 | -6.145 | -2.720 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | 977 | 4.995 | -1.954 | -6.575 | -2.789 | 0 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Girasole Pharmacy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.184 | 664 | 162 | 23 | 0 | 0 |
| Current Assets | - | - | - | - | 17.661 | 22.102 | 22.596 | 17.471 | 9.969 | 9.913 |
| Inventories | - | - | - | - | 15.514 | 14.692 | 15.503 | 8.067 | 7.398 | 7.357 |
| Receivables | - | - | - | - | 1.055 | 2.358 | 1.589 | 1.255 | 677 | 673 |
| Cash | - | - | - | - | 1.092 | 5.052 | 5.505 | 8.149 | 1.894 | 1.883 |
| Shareholders Funds | - | - | - | - | 573 | 5.565 | 3.488 | -3.076 | -5.856 | -5.824 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 18.272 | 17.200 | 19.271 | 20.570 | 15.825 | 15.737 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Girasole Pharmacy S.r.l.